We aspire to significantly enhance the quality of life and care of women by empowering patients and health care professionals with intelligent drug delivery and diagnostics. We are developing a unique platform in the field of smart therapies with a market launch planned in 2024 that has the potential to transform the way women are treated, monitored, and diagnosed.
Willem de Laat MD, PhD, MBA
CEO & FOUNDER Willem is the visionary father of LiGalli and acts as CEO and CTO of the company. His responsibilities are product development, partnerships, and external communication.